Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis
暂无分享,去创建一个
Sarah Fidler | H. Ward | Sung-Hee Kim | Helen Ward | Sung-Hee Kim | Sarah M. Gerver | S. Fidler | S. Gerver | Sarah M. Gerver
[1] E. S. Pearson,et al. THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .
[2] S. Marhefka,et al. Transmission Risk Behavior Among Youth Living with Perinatally Acquired HIV: Are Nonadherent Youth More Likely to Engage in Sexual Behavior? , 2010 .
[3] R. Chaisson,et al. Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa , 2009, Journal of acquired immune deficiency syndromes.
[4] S. Nogueira,et al. Factors associated with lack of antiretroviral adherence among adolescents in a reference centre in Rio de Janeiro, Brazil , 2008, International journal of STD & AIDS.
[5] D. Ross,et al. HIV prevention in young people in sub-Saharan Africa: a systematic review. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[6] Carlos Del Rio,et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] I. Litt,et al. Compliance with medical regimens during adolescence. , 1980, Pediatric clinics of North America.
[8] S. Reisner,et al. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. , 2009, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[9] Crystal Chan,et al. Opportunity in crisis , 2011 .
[10] A. d’Arminio Monforte,et al. Response to combination antiretroviral therapy: variation by age , 2008, AIDS.
[11] N. Santos,et al. Long-term follow-up outcomes of perinatally HIV-infected adolescents: infection control but school failure. , 2010, Journal of tropical pediatrics.
[12] S. Rugină,et al. Long-term Follow-up of 414 HIV-Infected Romanian Children and Adolescents Receiving Lopinavir/Ritonavir-Containing Highly Active Antiretroviral Therapy , 2007, Pediatrics.
[13] P. Musoke,et al. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala , 2007, Annals of tropical paediatrics.
[14] M. Chesney,et al. Adherence to HAART regimens. , 2003, AIDS patient care and STDs.
[15] P. Musoke,et al. Antiretroviral therapy for HIV-1 infected adolescents in Uganda: Assessing the impact on growth and sexual maturation , 2008, Journal of Pediatric Infectious Diseases.
[16] H. Bang,et al. Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. , 2008, Bulletin of the World Health Organization.
[17] A. Rodger,et al. Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults , 2011, PloS one.
[18] Y. Cao,et al. HIV-1 drug resistance in newly infected individuals. , 1999, JAMA.
[19] S. Nachman,et al. The link between religion and HAART adherence in pediatric HIV patients , 2010, AIDS care.
[20] Marcos Tadeu Nolasco da Silva,et al. Usefulness of pharmacy dispensing records in the evaluation of adherence to antiretroviral therapy in Brazilian children and adolescents. , 2012, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[21] J. Caylà,et al. Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV‐Infected Patients , 2002, Journal of acquired immune deficiency syndromes.
[22] I. Buchan,et al. Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America , 2006 .
[23] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[24] D. Swendeman,et al. Use of HAART among young people living with HIV. , 2003, American journal of health behavior.
[25] K. Riekert,et al. Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible. , 2004, AIDS patient care and STDs.
[26] M. Sharland,et al. Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. , 2009, AIDS patient care and STDs.
[27] N. Ford,et al. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review , 2012, Journal of the International AIDS Society.
[28] E. Baer. In Crisis , 1970, The American journal of nursing.
[29] Márcia Dal Fabbro,et al. Characteristics of HIV-positive patients infected by vertical transmission, Campo Grande, MS, Brazil, 1993–2009 , 2012, Sexually Transmitted Infections.
[30] S. Zeichner,et al. Cognitive Functioning in School-Aged Children With Vertically Acquired HIV Infection Being Treated With Highly Active Antiretroviral Therapy (HAART) , 2006, Developmental neuropsychology.
[31] E. Remor,et al. Adherence to ARV medication in Romanian young adults: Self-reported behaviour and psychological barriers , 2013, Psychology, health & medicine.
[32] D. Murphy,et al. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA , 2001, AIDS care.
[33] Chengcheng Hu,et al. Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability. , 2009, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[34] L. Conner,et al. Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV. , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[35] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[36] R. Hays,et al. A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors , 2001, Annals of Internal Medicine.
[37] M. Hughes,et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. , 2004, The Journal of infectious diseases.
[38] J. Parsons,et al. Health literacy and antiretroviral adherence among HIV-infected adolescents. , 2010, Patient education and counseling.
[39] G. Luftman,et al. Antiretroviral adherence issues among HIV-positive adolescents and young adults. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[40] T. Hart,et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis , 2012, The Lancet.
[41] G. Guyatt,et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. , 2006, JAMA.
[42] D. Paterson,et al. Measurement of Adherence to Antiretroviral Medications , 2002, Journal of acquired immune deficiency syndromes.
[43] Susan Swindells,et al. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.
[44] Patrick A Ryscavage,et al. Clinical Outcomes of Adolescents and Young Adults in Adult HIV Care , 2011, Journal of acquired immune deficiency syndromes.
[45] Paige L. Williams,et al. Predictors of Adherence to Antiretroviral Medications in Children and Adolescents With HIV Infection , 2006, Pediatrics.
[46] Ashley L. Buchanan,et al. Barriers to Medication Adherence in HIV-Infected Children and Youth Based on Self- and Caregiver Report , 2012, Pediatrics.
[47] J. Ellen,et al. The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care. , 2012, AIDS patient care and STDs.
[48] D. Harris,et al. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. , 2009, AIDS patient care and STDs.
[49] Á. Holguín,et al. High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain , 2012, PloS one.
[50] N. Lapointe,et al. The Young and the Resistant: HIV-Infected Adolescents at the Time of Transfer to Adult Care. , 2013, Journal of the Pediatric Infectious Diseases Society.
[51] David R Bangsberg,et al. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] D. Costagliola,et al. Evaluation of a peer support group therapy for HIV-infected adolescents , 2005, AIDS.
[53] G. Harper,et al. Predictors of medication adherence among HIV-infected youth , 2005, Psychology, health & medicine.
[54] A. Mocroft,et al. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. , 2000, Archives of internal medicine.
[55] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[56] S. Calabrese,et al. Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents , 2012, AIDS care.
[57] B. Berger,et al. Patient Treatment Adherence , 1992, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.
[58] Doris Ma Fat,et al. WHO Library Cataloguing-in-Publication Data , 2001 .
[59] S. Lawn,et al. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa , 2012, BMC Infectious Diseases.
[60] R. Succi,et al. Pregnancy in HIV vertically infected adolescents and young women: a new generation of HIV-exposed infants , 2010, AIDS.
[61] H. Omar,et al. Brazilian Adolescents Infected by HIV: Epidemiologic Characteristics and Adherence to Treatment , 2009, TheScientificWorldJournal.
[62] S. Macleod,et al. Adherence to Antiretroviral Therapy in HIV-Positive Adolescents in Uganda Assessed by Multiple Methods A Prospective Cohort Study , 2012 .
[63] S. Macleod,et al. Adherence to Antiretroviral Therapy in HIV-Positive Adolescents in Uganda Assessed by Multiple Methods , 2012, Pediatric Drugs.
[64] K. Fennie,et al. Adherence to Antiretroviral Medication Among HIV-Positive Patients in Thailand , 2006, Journal of acquired immune deficiency syndromes.
[65] D. Harris,et al. Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States. , 2010, AIDS patient care and STDs.
[66] N. Gravato,et al. Vulnerability, human rights, and comprehensive health care needs of young people living with HIV/AIDS. , 2006, American journal of public health.
[67] C. Rouzioux,et al. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. , 2012, The Journal of infectious diseases.
[68] M. Maskew,et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. , 2013, AIDS research and human retroviruses.
[69] H. Carvalho,et al. Antiretroviral therapy adherence in Brazil , 2004, AIDS.
[70] A. Moscicki,et al. Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. , 2011, AIDS patient care and STDs.
[71] C. Rouzioux,et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[72] A. Elgalib,et al. Hiv positive adolescents: characteristics and treatment challenges , 2012 .
[73] P. Phanuphak,et al. Health risk behaviors among HIV-infected youth in Bangkok, Thailand. , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[74] Hiv Diagnosesa. HIV in the United States: At A Glance , 2013 .
[75] M. Hughes,et al. Long-term observation of adolescents initiating HAART therapy: three-year follow-up. , 2007, AIDS research and human retroviruses.
[76] A. Moscicki,et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. , 2003, Archives of pediatrics & adolescent medicine.
[77] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[78] C. Tebbi,et al. Treatment compliance in childhood and adolescence , 1993, Cancer.
[79] W. Ko,et al. Clinical and laboratory characteristics of human immunodeficiency virus-infected adolescents: experience from a single medical center. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.